TY - CHAP M1 - Book, Section TI - Anesthesia for Patients with Endocrine Disease A1 - Alexanian, Sara A1 - Lee, Stephanie L. A1 - Peterfreund, Robert A. A2 - Longnecker, David E. A2 - Mackey, Sean C. A2 - Newman, Mark F. A2 - Sandberg, Warren S. A2 - Zapol, Warren M. Y1 - 2017 N1 - T2 - Anesthesiology, 3e AB - KEY POINTSEndocrine diseases are common comorbid conditions in surgical patients.The patient’s type of diabetes mellitus must be known and the differing therapies for types 1 and 2 appreciated.Frequent monitoring of glucose levels is a mainstay in management of the diabetic patient undergoing anesthesia and surgery.General anesthesia may mask the signs and symptoms of hypoglycemia; signs of hypoglycemia (tachycardia, sweating) may be misinterpreted as “light anesthesia”.Tight perioperative glucose control is no longer generally recommended. Consider keeping glucose levels at <150-180 mg/dL.Hypothyroid patients may exhibit sensitivity to sedative and hypnotic drugs used perioperatively. Hemodynamic instability should be anticipated.Hyperthyroid patients may exhibit dehydration and hemodynamic instability and are at particular risk for tachydysrhythmias, metabolic or vascular decompensation, and thyroid storm.The airway is a key consideration in patients undergoing thyroid surgery.Pheochromocytoma patients require careful preoperative preparation, and plans must be made to monitor and manage hemodynamic extremes during surgery.Glucocorticoid deficiency in patients at risk for adrenal insufficiency should be anticipated. Consider careful titration of supplemental steroid therapy.The implications of growth hormone excess (acromegaly) and adrenal steroid excess (Cushing disease) should be considered when preparing patients for pituitary surgery. SN - PB - McGraw-Hill Education CY - New York, NY Y2 - 2024/04/16 UR - accessanesthesiology.mhmedical.com/content.aspx?aid=1144132152 ER -